GIOVANNI FATTORE. Curriculum Vitae

Transcript

1 GIOVANNI FATTORE Curriculum Vitae Personal data Giovanni Fattore Date and place of birth: November 16, 1963, Florence Married, 1 child Resident in Viale F. Crispi n 5 Milano Academic Positions in Italy 2007 September Executive Committee, Department of Institutional Analysis and Public Management, Bocconi University January present Executive Committee, Centre Carlo F Dondena on Social Dynamics, Bocconi University April 2006 September Acting Director, CERGAS (Centre for Research on Healthcare Management and Social Care), Bocconi University January present Research Committee, Bocconi University 2005 September present Associate Professor of Public and Healthcare Management, Bocconi University January present Executive Committee, Vice-director for international projects, CERGAS April 2008 June Director, Master of International Healthcare Management, Economics and Policy (MIHMEP), Bocconi University February 2005 August Associate Professor of Management, Parthenope University, Naples June 2002 January Assistant Professor of Public Management (Ricercatore), Bocconi University February 1997 May Research Fellow, CERGAS, Bocconi University & Research Officer ( Amici della Bocconi scholarship), CERGAS. International Academic Positions January 2008 Instructor, New Public Management, Master in non-profit management, Insbruck Management Centre, Insbruck 1998 February 2001 March Instructor, Health Policy and Quality Management, Institute of Public Health and University of Malta January Instructor, Comparative Healthcare Systems, Msc in Health Policy and Management, John Vianey Institute, Lahore, Pakistan September October Visiting Researcher, LSE-Health (London School of Economics), sponsored by CNR (Italian Research Council), short-term mobility program April Instructor, Principles of Pharmacoeconomics, Faculty of Medicine, Pontifical University of Chile, Santiago, Chile January 1997 June Research Officer, LSE-Health, London School of Economics September 1993 June Teaching Assistant, Harvard School of Public Health (course in Decision Analysis, main instructor Prof. M.C. Weinstein). 1

2 Education 2008 PhD in Social Policy, London School of Economics and Political Science (Tutor Julian Le Grand; thesis title A Cost.Benefit Analysis of In-Vitro-Fertilization in Italy ) 1996 January 1997 June Courses in Research Methodology and Health Policy Research, London School of Economics June MSc (2 years) in Health Policy and Management, Harvard University (Decision Sciences track) March Course Learning how to teach, SDA Bocconi School of Management Laurea degree in Economics (5 year programme) (DES, Discipline Economiche e Sociali) summa cum laudae, Bocconi University. Honors and Awards 2009 Bocconi University, Research Profile for academic years Bocconi University, Excellence Research Award CUD (Committee for Medical Devices) Italian Ministry of Health-, Expert Hearing about the use of economic evaluation for medical devices Bocconi University, Research Paper Award Italian Department of Health, Official acknowledgement of contribution to the analysis of the damage sustained by the Treasury resulting from pharmaceutical policy in the period Bocconi University, recipient of the President s Scholarship for Studies Abroad Bocconi University, top graduates award, academic year Government Research Grants (EU and Italy) Sport & Social Capital (MEXT-CT ) (Scientist in Charge since January 2008), Health Basket (EU SP21-CT ), Social Costs of Alzheimer Disease (EU XT5-1998), Medicine for Managers (EU 1996); PRIN 2007 (local unit leader), PRIN 2003 (local unit leader), COFIN 2001 (local unit leader), COFIN 1999 (participant). Refereeing European Journal of Public Health, Journal of Health Politics Policy and Law, British Medical Journal, Health Policy, Health Economics, Value in Health, European Management Review (special associate editor), International Journal of Integrated Care, Journal of Management and Governance, Alzheimer Disease and Associated Disorders, European Journal of Health Economics, International Journal of Health Planning and Management, Epidemiologia e Psichiatria Sociale, Pharmacoeconomics Italian Research Articles, Annali di Economia, Mecosan, Academy of Management Annual Conference. Editorial Boards Politiche Sanitarie, Pharmacoeconomics Italian Research Articles (associate editor),italian Heart Journal ( ), Mecosan, Eurohealth. 2

3 Scientific Associations Treasurer and Board member ( ), European Association of Health Management (EHMA) Board member (2002 to present), Vice President ( ) and President (from 2008), Italian Health Economics Association (AIES). Member, Scientific Advisory Committee, European Health Management Association ( ). Member, International Advisory Board of Health Management, Management Education & Research Consortium (M.E.R.C), Washington D.C (2006 to present). Member, European Health Policy Research Network (led by the London School of Economics) ( ). Member, Scientific Committee, Observatory on Health, Catholic University, Roma (2002 to present). Member, Board of the Heart Foundation (non-cardiologist member of the Foundation of the Italian Association of Hospital Cardiologists) ( ). Main international conferences and seminars - DRGs: How, what why. The DRG as a financial tool. Bruxelles; European Parliament. Conference organized by EHMA and HOPE, 5 th March PhD workshop, The Social Impact of Sport Management and Governance, Università Bocconi, 20 November, Financing the social role of sport (session chair), The Social Impact of Sport Management and Governance, November, th European Health Economics Conference. The Italian National Health Service. Is Still National? Rome, 24 July, 2008 (with F Longo). - IGR and the Welfare (Co-chair), The Status Inter-Governmental Relations, Fourth Transatlantic Dialogue, Milan, June, Conference of the American Evaluation Association. Process and use learning: a different perspective. The case of the World Bank. Baltimore, 6-8 November 2008 (with S Paruzzolo). - HealthBasket Final Conference, Health baskets in Europe, 22 February, Royal Holloway University (London University) PSRO seminar series, Health reforms in Italy ten years later, University of London, December WHO Europe, European Observatory on Health Care Systems and Government of Albania, Private medicine and dual practice: the European experience (WORKSHOP), Tirana, 1-2 December XXVII Conference of ALASS (Association for the Analysis of Latin Health Care Systems), Health care systems from globalization to local responses, The impact of globalization on social justice, Milan, 6 October (with C De Pietro). - First EGPA (European Group for Public Administration) PhD and young research seminar, convener of the event, Milan, 4-6 September Second Annual HTAi Meeting (Bringing HTA into Practice), Decision making in Italian healthcare: are economic studies used by decision makers, Rome, 20 June International Society for Pharmacoeconomics and Outcome Research (ISPOR), The use of economic evaluation in the Italian NHS, Hamburg, October Eucomed General Assembly (Forum on Economics of medical technologies), Medical Technology Innovations: how can we afford it? Prague, 12 October Creating Actionable Knowledge for Managing Change (International workshop to celebrate the XXV anniversary of CERGAS), Economic evaluation in health care: are studies used by decision makers?, Portofino, 9-10 September Creating Actionable Knowledge for Managing Change (International workshop to celebrate the XXVanniversary of CERGAS), Portofino, September 2004 (Scientific coordinator). - European Observatory on Health Care Systems, LSE and Government of Greece, Pharmaceutical Policy in the European Union (workshop), The regulation of pharmaceutical market in Italy, Athens, 13 June 2003 (with C Jommi). 3

4 - European Health Management Association Annual Conference, Should In Vitro Fertilisation be publicly funded: a cost-benefit analysis for Italy, Orebro (Sweden), 23 June European Health Policy Research Group (London School of Economics), Italian Health Policy, 7 February European Health Management Association Annual Conference, Managing the demand side of health care systems: comparing British and Italian primary care, Parma (Italy), June European Health Policy Research Network, Rationing and Priority Setting in Italy, Athens, September European Health Policy Forum, Market forces in European Health Care Systems: the industry perspective, Louvain, 10 March European Association of Self Medication, The Economic and social value of self-medication: an Italian Study, Budapest, 6 September Main scientific research projects and streams of research The Italian healthcare reform: 30 years later. In preparation of various events celebrating the 30 th anniversary of the Italian NHS I have reviewed its developments with reference to the concept of governmentality. Main scientific output: an article in Politiche Sanitarie (forthcoming) and an abstract for EURAM Social network analysis in primary care. I am leading two research projects on the use of SNA to understand how knowledge is used and transferred among Italian GPs. We found little evidence that institutional networks have an impact on physician s prescribing behavior. I have recently won a PRIN (Italian university research grant) on this topic Voluntary Health Insurance (VHI) in Serbia. I prepared a policy paper for the World Bank about the present situation and future developments of VHI in Serbia with a detailed review of VHI in 8 European countries Universalism and excellence in the Regional Health Care System of Friuli Venezia Giulia. I coordinated a project to review the institutional arrangements of the FVG regional healthcare system and to recommend changes to the Governor of the Region. All top managers of the regional health care system were interviewed and data of hospital activities analyzed Impact of economic evaluation on decision making processes in the Italian NHS. I investigated how economic evaluation principles and tools are used by decision makers at policy, management and professional levels. Main research outputs: a paper presented at the ISPOR conference in Hamburg (2004), two papers presented at the National Conference of the Italian Health Economics Association and the manuscript Economic evaluation in health care: are studies used by decision makers? (published in Value in Health) Health Benefits and Service Costs in Europe HealthBASKET. The project was funded by the European Commission within the Sixth Framework Research Programme (Grant: SP21- CT ) and coordinated by Prof. Reinhard Busse, from the Dept. of Health Care Management at the Technische Universität Berlin. I act as coordinator of the Bocconi team. The study investigates basic healthcare packages in 8 EU member states through the collection of original data on costs from a sample of European healthcare institutions. It aims at defining and testing a new costing methodology to be used in Europe. Publications in The European Journal of Health Economics and Health Care Management Science Pharmaceutical Observatory. The Observatory, established in 1997 as a unit of CERGAS- Bocconi, carries out regular studies on Italian pharmaceutical policy, focusing on its impact 4

5 on the performance of healthcare organizations. It delivers two annual reports and occasional discussion papers. I was head of the Observatory from 1997 to 2000 and I now act as scientific supervisor. Main outputs: The New Pharmaceutical Policy in Italy, Health Policy 1998, The last decade of Italian pharmaceutical policy: instability or consolidation, Pharmacoeconomics 2008, several articles in Italian scientific journals and informative articles for Eurobserver, the Newsletter of the European Observatory on Health Care Systems. The Pharmaceutical Observatory organised two international conferences at Bocconi University (2000 and 2003) with prominent speakers from UK, Germany and the US Economic evaluation of health care programmes and technologies. Since 1994, I have been acting as scientific coordinator of the CERGAS unit on economic evaluations. The unit has carried out several multi-centre empirical studies in cooperation with clinicians and epidemiologists. Collection and analysis of primary data are performed to conduct cost-ofillness, cost-effectiveness, cost-utility and cost-benefit studies. The unit has investigated drugs, new technologies and other healthcare programmes in the field of psychiatry, cardiology, neurology, assisted reproductive medicine and public health. Main outputs: The costs of multiple sclerosis: a cross-sectional, multi-center cost-of-illness study in Italy, Journal of Neurology 2002; Costs of pharmaceutical treatments in major depression patients in Italy Pharmacoeconomics 2000; Mental Health Care in Italy: Organisational Structure, Routine Clinical Activity and Costs of a Community Service in Lombardy Region International Journal of Social Psychiatry 2000; Health care costs of therapyrefractory schizophrenic patients treated with clozapine: a study in a Community Psychiatric Service in Italy, Acta Psychiatrica Scandinavica 1999; The Economic and Social Burden of Alzheimer Disease on Families in Lombardy Region, Italy, Alzheimer Disease and Associated Disorders Comparative analysis of healthcare systems and policies. I have investigated health care systems of the United States, Canada, United Kingdom, Germany, and several developing countries. These research activities sustained my role as the Director of the Master of International Healthcare Management, Economics and Policy. Main outputs: "Assetti federali in Sanità: cosa possiamo imparare da Canada e Stati Uniti?", (in the 2003 Smith- Kline Foundation Report) and Universalismo e sviluppo tecnologico: i sistemi sanitari della Germania, del Regno Unito e degli Stati Uniti, published in Rivista delle Politiche Sociali In 2003, I co-authored the report: Health Care Financing: Options for the Syrian Arab Republic, sponsored by Italian Ministry of Foreign Affairs and presented to the SAR Ministry of Health Managerialism in the Italian NHS. I am active in CERGAS Observatory on Managerialism in the Italian NHS (OASI) and I prepared reports on regional health planning and, business consultants perception of managerialism and health technology assessment. These reports were published in the annual reports of the Observatory ( ) Vocational training in health management and economics in the European Union. I was member of the international team coordinated by LSE-Health investigating vocational training in the are of health economics and management. The study was based on a national survey of health professionals needs for training in management and economics Priority setting in health care. The project, coordinated by Prof. Elias Mossialos of the London School of Economics, investigated rationing and priority setting of health services in 10 EU member states. I wrote the Italian case and analysed data resulting from/generated by the Eurobarometer survey. Main outputs: one paper presented at an international workshop held in Athens in 1998 and the article Clarifying the scope of Italian NHS coverage: Is it feasible? Is it desirable? in Health Policy

6 Health Care and Cost Containment in the European Union. The project, coordinated by Prof. Elias Mossialos Julian Le Grand (LSE), investigated healthcare cost containment policies in 12 UE member states. I was in charge of the Italian and the British study and, during my stay in London from January 1996 to June 1997, I acted as coordinator of the overall project. Main outputs: presentations in three workshops held in London and Brussels and two chapters of the book Health Care and Cost Containment in the European Union edited by E Mossialos and J Le Grand Health in Transition Profile United Kingdom -. I systematically reviewed the scientific literature on the British NHS and drafted the Health in Transition Profile, a detailed description of the British system, eventually published by the European Observatory on Health Care Systems Cost-effectiveness analysis of prevention programmes for HIV. While at the Harvard School of Public Health, I designed a simulation model to assess costs and outcomes of strategies to prevent HIV and AIDS. Methods and results of the project were presented at a seminar for the faculty and were published in the article "Economic Evaluation of HIV Testing Among Intravenous Drug Users: Analytic Framework and Application to Italy", International Journal of Technology Assessment in Health Care, PhD supervision Stefano Calciolari (Università di Parma, Public Management, XVI ciclo, 2004), Valutazione economica dell introduzione delle ICT nella pubblica amministrazione. Aleksandra Torbica (Università di Parma, Public Management, XIX ciclo, 2007), Tariff Setting in the Italian National Health Service. Irene Colangelo (Università di Parma, Public Management, XX, Ciclo 2008), L evoluzione del sistema di finanziamento delle aziende sanitarie tramite DRG: Analisi delle scelte delle regioni italiane. Monica Otto (Università Bocconi, Business Administration and Management, XX ciclo, 2008), The role of public administration in supporting biotech clusters. Antonio Lapenta (Università Magna Grecia di Catanzaro, Economia e Management in Sanità, 2008), La partecipazione é il suo contrario: Il Caso dell Agenda di Riforma SP2010 Domenico Salvatore (Università Bocconi, Business Administration and Management, XIX Ciclo, 2008), A Relational Approach to Health Care Management. Hans Dubois (Università Bocconi, Business Administration and Management, 2009) Decentralization in Public Administration. Silvia Paruzzolo (Università Bocconi, Business Administration and Management, 2009) Participatory evaluation as a tool to foster organizational learning: theory and evidence from the World Bank. Teaching Assignments (Bocconi University) Institutions, Government and Society, Public Management Public Management, Management of Health Care and Social Services Public Management, Management of Human Capital Services, Management of Health Services and Social Care (Bocconi and Vancouver Campus Abroad) Advanced Public Management (for the PhD programme in Business Administration and Management) Management of Human Capital Services, Management of Health Services and Social Care and Pharmaceutical and Biotech Industry Laboratory Advanced Public Management (for the PhD programme in Business Administration and Management), Management of Human Capital Services, Management of Health Services and Social Care, Pharmaceutical and Biotech Industry Laboratory Management of Human Capital Services, Pharmaceutical and Biotech Industry Laboratory. 6

7 Management of Human Capital Services, Pharmaceutical and Biotech Industry Laboratory, Health Care Systems and Management Health Care Systems and Management, Comparative Public Management Health Care Systems and Management, Comparative Public Management, Healthcare Management Health Care Systems and Management, Comparative Public Management, Healthcare Management, Public Management Health Care Systems and Management, Comparative Public Management, Healthcare Management, Public Management Main instructor, Health Care Systems and Management, Instructor, Comparative Public Management, Healthcare Management, Public Management Main instructor, Health Care Systems and Management, Comparative Public Management, Healthcare Management Comparative Public Management, Evaluation of Public Programmes, Public Management Evaluation of Public Programmes Evaluation of Public Programmes, Public Management Evaluation of Public Programmes. Teaching and Management (SDA -Bocconi School of Management-) - Core Faculty - Director, Master of International Healthcare Management, Economics and Policy (MIHMEP) ( ). - Main instructor, Healthcare Systems and Policy (MIHMEP), Comparative Healthcare Systems (Master in Management Sanitario), Evaluation of Public Programmes (Master in Public Management). - Main Instructor, Strategic Planning, Executive Programme on Management for Health Professionals (CorGeSan) (from 1994). - Main instructor, Quality management, Executive program for Italian NHS general managers - Instructor, Module on Business in the pharmaceutical sector, Master in Business Administration ( ). - Instructor, courses and seminars on health planning, strategic planning, quality management, knowledge management, economic evaluation of healthcare programmes, management of pharmaceutical services, health technology assessment, marketing in the pharmaceutical sector. Teaching Assignments (Parthenope University, Naples) Introduction to Business Administration, Public Management, Healthcare Management Introduction to Business Administration, Public Management, Healthcare Management Public Management, Healthcare Management Enterprise Management. Other - Expert (reviewer) MAS Net-Megs in Economia e gestione sanitaria e sociosanitaria, Lugano, Switzerland (September 2008-December 2008) - Member, Evaluation committee, Research Grants for Clinical Governance (4 Million Euros), Emilia Romagna, Italy (October- 2008) - Member, Health Technology Assessment Expert Group, Lombardia Region, December Author of dissemination articles published in Eurohealth and Eurobserver (international) and Sole 24, Sole 24 Sanità, Prospettive Sociali e Sanitarie (Italian). 7

8 GIOVANNI FATTORE List of Publications Articles in Scientific Journals (English) Dubois H, Fattore G, Definitions and typologies in public administration research: The case of decentralization, International Journal of Public Administration 2009; 32(8): Cappellaro G, Fattore G, Torbica A, Funding and Regulating Health Technologies in Decentralized Systems: A Comparison between Italy and Spain, Health Policy 2009; 92(3) , (2009). Fattore G, Frosini F, Salvatore D, Tozzi V, Social Network Analysis in Primary Health Care: the impact of interaction on prescribing behaviour, Health Policy 2009; 92(3): Gerzeli S., Torbica A, Fattore G Cost Utility Analysis of knee prosthesis with complete microprocessor control (C-leg) compared with mechanical technology in trans-femoral amputees, The European Journal of Health Economics (HEPAC) 2008; 2: Fattore G, Jommi C The last decade of Italian pharmaceutical policy: instability or consolidation?, Pharmacoeconomics 2008; 26(1):5-15. Fattore G, Torbica A Cost and reimbursement of cataract surgery in Europe: a cross-country comparison, Health Economics, 2008; 17 (S1): S71-S82. Compagni A, Bartoli S, Buehrlen B, Fattore G, Ibarreta D, de Mesa EG Avoiding adverse drug reactions by pharmacogenetic testing: A systematic review of the economic evidence in the case of TPMT and AZAinduced side effects. International Journal of Technology Assessment in Health Care 2008; 24(3): Fattore G, Factors Affecting an Economic Model for Zoster Vaccination, Herpes 2007; 14 (S2): 52A-55A. Fattore G, Torbica A Inpatient reimbursement system in Italy: How do tariffs relate to costs? Health Care Management Science 2006; 9: Fattore G, Torbica A. Economic evaluation in health care: the point of view of informed physicians, Value in Health 2006; 9(3): Torbica A, Fattore G. The "Essential Levels of Care" in Italy: when being explicit serves the devolution of powers, The European Journal of Health Economics (HEPAC) 2005; 6: Amato, MP, Battaglia MA, Caputo D, Fattore G, Gerzeli S, Pitaro M, Reggio A The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in Italy, Journal of Neurology 2002; 249(2): Percudani M, Fattore G, Belloni GC, Gerzeli S, Contini A Service utilization and costs of first-contact patients in a community psychiatric service in Italy, European Psychiatry 17 (8); 2002: Fattore G, Percudani M, Pugnoli C, Contini A, Beecham J Mental Health Care in Italy: Organisational Structure, Routine Clinical Activity and Costs of a Community Service in Lombardy Region, International Journal of Social Psychiatry 2000; 46(4): Tarricone R, Fattore G, Gerzeli S, Taddei C, Percudani M, Costs of pharmaceutical treatments in major depression patients in Italy Pharmacoeconomics 2000; 15:

9 Fattore G, Clarifying the scope of Italian NHS coverage: Is it feasible? Is it desirable? Health Policy 1999; 50: Percudani M, Fattore G, Galletta J, Mita P, Altamura C Health care costs of therapy-refractory schizophrenic patients treated with clozapine: a study in a Community Psychiatric Service in Italy, Acta Psychiatrica Scandinavica 1999; 99: Fattore G, Jommi C, The New Pharmaceutical Policy in Italy, Health Policy 1998; 46 (1); Lorenzoni R, Pagano D, Mazzotta G, Rosen D, Fattore G, Gensini G, Pitfalls in the economic evaluation of thrombolysis in myocardial infarction, European Heart Journal 1998; 19(10): Cavallo M C, Fattore G The Economic and Social Burden of Alzheimer Disease on Families in Lombardy Region, Italy, Alzheimer Disease and Associated Disorders 1997; 11(4): Villari P, Fattore G, Siegel J, Paltiel D, Weinstein M, "Economic Evaluation of HIV Testing Among Intravenous Drug Users: Analytic Framework and Application to Italy", International Journal of Technology Assessment in Health Care, 1996; 12(2): Book chapters (English) Fattore G, Cost-containment and reforms in the Italian National Health Service. In: Mossialos E, Le Grand J, editors. Health Care and Cost Containment in the European Union. Aldershot: Ashgate 1999; Fattore G, Cost-containment in the British National Health Service. In: Mossialos E, Le Grand J, editors. Health Care and Cost Containment in the European Union. Aldershot: Ashgate. 1999: Articles in Scientific Journals (Italian) Fattore G, Crisio economica, salute e sistema sanitario, Politiche Sanitarie 2009; 19(2): Fattore G, Politica, aziende, professionisti e pazienti: 30 anni di governo del Ssn (Politics, organizations,professionals and patients: governing the Italian NHS in the last 30 years), Politiche Sanitarie 2008; 9(4): Fattore G, I National Health Service del Regno Unito: verso il modello italiano? (The British NHS: towards the Italian model?), Mecosan 2008; 65: Fattore G, Jommi C. La politica farmaceutica in Italia nell ultimo decennio (Pharmaceutical policy in the last decade), Pharmaceonomics Italian Research Articles 2008; 9(3) Fattore G, Torbica A, Il ruolo delle variabili organizzative nella diffusione dell innovazione tecnologica: il caso dell infarto miocardico acuto (The role of organizational variables in the diffusion of technological innovations: the case of Acute Miocardial Infarction), Economia e Politica del Farmaco 2007; 7: Aguzzi G, Fattore G, L analisi dei costi di produzione dei servizi e l utilizzo delle tariffe nelle valutazioni economiche in sanità (Cost analysis and tariffs in economic evaluation studies), Pharmaceonomics Italian Research Articles 2006; 8(1): Fattore G, Landolina M, Bontempi L, Cacciatore G, Curnis A, Gilizia M, Padeletti L, Mazzei L, Tavazzi L, L impatto economico della terapia di resincronizzazione in pazienti con scompenso cardiaco. Evidenze 9

10 disponibili e valutazione del modello CRT-Eucomed per l analisi dei rapporto costo-efficacia, (The economic impact of resyncronisation: an economic simulation) Italian Heart Journal 2005: 6(12): Fattore G, Torbica A, Mangone M, Analisi dei costi di quattro strategie terapeutiche nella gestione di pazienti con broncopneumopatia (BPCO) moderata o severa: un applicazione del metodo bootstrap (Cost analysis of 4 strategies for the management of patients with moderate or severe bronchoneopathy: a bootstrap analysis), Pharmacoeconomics Italian Research Articles 2005; 7(2): Fattore G, Costi ed efficacia devono essere scontati allo stesso tasso? (Should cost and effectiveness be discounted at the same rate?) Pharmacoeconomics Italian Research Articles 2005; 7(1): 5-7. Fattore G, Universalismo e sviluppo tecnologico: i sistemi sanitari della Germania, del Regno Unito e degli Stati Uniti (Universalism and technological development: the health care systems of Germany, UK and United States), Rivista delle Politiche Sociali 2004; 4: Fattore G, Colangelo I, Martelli E, Cheli A, Del Sasso L, Metodi e costi della profilassi della trombosi venosa profonda in chirurgia ortopedica in Italia, (Methods of prevention and costs of deep trombosis in orthopaedic surgery patients) Pharmacoeconomics Italian Research Articles 2004; 6(2): Percudani M, Gerzeli S, Massagrandi R, Jommi C, Fattore G, Cerati G, Contini A "Costi ed esito dell'assistenza nei soggetti con disturbo mentale grave" (Cost and outcome for care of severe psychiatric disorders), Epidemiologia e Psichiatria Sociale 2003; 12(3): Fattore G, Lazzaro C Analisi dei costi della somministrazione di albumina nel paziente cirrotico con ascite (Cost analysis of albumina in cirrosis patients), Mecosan 2001; 40: Bensa G, Fattore G Il Piano Sanitario dell Oregon: la strategia politica del razionamento (The Oregon Plan: the political strategy of rationing), Mecosan 2000; 36: Fattore G, Lazzaro C Analisi dei costi del trattamento della menoraggia (Cost analysis of menhoraggia treatments), Pharmacoeconomics Italian Research Articles 1999; 1(1): Attanasio E, Bruzzi P, Capri S, Ceci A, Fattore G, Mantovani L, Raccomandazioni per la conduzione degli studi di farmacoeconomia: la gida GISF (Reccomendations to conduct pharmacoeconomic studies) Mecosan 1999; 29: Fattore G, Lazzaro C Analisi costi-efficacia della fertilizzazione in vitro in Italia (Cost-effectiveness analysis of In-Vitro-Fertilization in Italy), Mecosan 1998; 25: Lorenzoni R, Fattore G, Gensini G Valutazione costi-efficacia della terapia trombolitica nell infarto miocardico acuto con Attivatore Tissutale del Plasminogeno o con Streptochinasi: la realtà italiana (Costeffectiveness analysis of thrombolytic therapies in AMI patients: the Italian situation), Giornale Italiano di Cardiologia 1997; 27(7): Fattore G, Percudani M, Tarricone R, Recchia M, Serra G, Taddei C L assistenza ospedaliera nella depressione maggiore: risultati di uno studio osservazionale multicentrico (Hospital care in major depression patients: results from a multi-centre study), Rivista di Psichiatria 1997; 32(5): Fattore G, Percudani M, Pugnoli C, Contini A, I costi delle prestazioni in psichiatria: un analisi condotta in un Centro Psico-Sociale pubblico (CPS) in Lombardia (Costs of psychiatric care in a Mental Health Centre in Lombardy Region), Epidemiologia e Psichiatria Sociale 1997; 6(2): Fattore G, Jommi C, Il prezzo dei farmaci innovativi tra regolazione pubblica e mercato (The price of innovative drugs), Mecosan 1997; 22:

11 Fattore G, Tabacchi M, Economia e Management: cosa ne pensano i medici: una indagine nazionale (Economics and management: what do doctors think about that?), Annali di Igiene, prevenzione e di Medicina di Comunità 1997; 9: Fattore G, Longo F, Il fundholding nel Regno Unito: appunti da un viaggio di studio (Fundholding in the British NHS: notes from a field trip), Mecosan 1996; 18: Fattore G, Sistemi di competizione amministrata nel SSN: modelli di finanziamento a tariffa e modelli negoziali (Systems of managed competition in the NHS:the tariff-based versus the purchaser-provider split model). Mecosan 1996; 19: Fattore G, "Analisi costi-efficacia del trattamento e della prevenzione con aspirina in pazienti con sospetto infarto miocardico acuto ed alto rischio di incidenti vascolari" (Cost-effectiveness analysis of suspected Acute Miocardial Infarction), Mecosan, 1995, 14: Percudani M, Fattore G, Strada L, Contini A, "La valutazione dei costi diretti e indiretti della depressione maggiore: applicazione di una metodologia di indagine in un servizio psichiatrico pubblico" (Cost analysis of major depression), Epidemiologia e Psichiatria Sociale: 1995, 4(3): Fattore G, Valutazione farmacoeconomica delle strategie di prevenzione degli eventi cardiovascolari (Pharmaco-economic analysis of cardiovascular prevention), Cardiologia 1995; 40 (12 Sup 1): Cavallo M C, Fattore G, "I costi sociali della Malattia di Alzheimer: metodologia e risultati di una indagine preliminare"(social costs of Alzheimer Disease), Mecosan 1994, 10: Fattore G, "Le risorse diminuiscono, i sistemi sanitari cambiano: due esempi, il sistema sanitario inglese e quello americano" (Diminuishing resources and increasing needs: how the Italian and British health care systems are changing), Giornale Italiano di Cardiologia 1994, 9: Fattore G, Meneguzzo M, Tarricone R (a cura di) "Who shall live, Who shall die?", Mecosan 1993, 5: Fattore G, "Il mercato assicurativo privato in sanità: cenni alla teoria economica" (Private health insurance in health care), Mecosan, 1993, 7: Fattore G, "Il sistema sanitario americano: tra crisi e innovazione" (The US health care system: between crisis and innovation), Mecosan 1992, 3: Fattore G, Garattini L, "L'allocazione delle risorse finanziarie nel Servizio Sanitario Nazionale: il quadro teorico e una soluzione pratica" (The allocation of financial resources in the Italian NHS), Economia Pubblica 1989, 12: Books and book chapters (Italian) Fattore G, Cavallo MC, Tarricone R, Lo sviluppo del Health Technology Assessment in Italia: contenuti, approcci e riferimenti internazionali (Health Technology Assessment in Italy). In Anessi Pessina E, Cantù E (a cura di), L aziendalizzazione in sanità in Italia. Rapporto OASI 2008, Milano, Egea, Fattore G, Rilevanza e complessità delle amministrazioni pubbliche (Relevance and complexity of public institutions). In Borgonovi E., Fattore G., Longo., F. (a cura di), Management delle Istituzioni Pubbliche, Milano, Egea, 2008 (3-16). 11

12 Borgonovi E, Fattore G, I concetti fondamentali per lo studio delle amministrazioni pubbliche (Fundamentals in the study of public management). In Borgonovi E, Fattore G, Longo F, Management delle Istituzioni Pubbliche, Milano, Egea, 2008 (17-32). Fattore G, Le funzioni delle istituzioni pubbliche (Main functions of public institutions). In Borgonovi E., Fattore G., Longo., F. Management delle Istituzioni Pubbliche, Milano, Egea, 2008 (33-46). Borgonovi E, Fattore G Caratteristiche e specificità del management pubblico (Peculiarity of public management). In Borgonovi E, Fattore G, Longo F. Management delle Istituzioni Pubbliche, Milano, Egea 2008 (47-62). Bartoli S, Fattore G Italia ed Europa, un confronto in sanità: il progetto EU Health Basket, (Italy and Europe: results from the Health Basket project). In Anessi Pessina E, Cantù E., L'aziendalizzazione in sanità in Italia. Rapporto OASI 2007, Milano, Egea, Aguzzi G, Fattore G, Lecci F I Piani Sanitari Nazionali: quale ruolo per lo Stato nella programmazione di un sistema decentrato (Health Planning: which role in the Italian NHS?), In Anessi Pessina E, Cantù E., L'aziendalizzazione in sanità in Italia. Rapporto OASI 2006, Milano, Egea, Prefazione. Spar D. Baby Business, Milano, Egea Fattore G, Scenari della sanità: il futuro dei servizi (Future scenarios for the Italian healthcare system: the organizational dimension), In Cislaghi C. Gli Scenari in Sanità, Milano, Franco Angeli, Fattore G, Lecci F I piani sanitari delle Regioni italiane (Regional health planning), In Anessi Pessina E, Cantù E., L'aziendalizzazione in sanità in Italia. Rapporto OASI 2005, Milan, Egea, Fattore G, Metodi di ricerca in economia aziendale (Research methods in management), Milan, Egea, Fattore G, L aziendalizzazione della sanità in Italia: la prospettiva dei consulenti (Managerialism in healthcare: what do consultants think?). In Anessi Pessina E, Cantù E., L'aziendalizzazione in sanità in Italia. Rapporto OASI 2004, Milano, Egea, Fattore G, Tozzi V, Innovazione di processo, knowledge practice e performance assistenziali: il caso dell Ospedale degli Infermi di Biella (Innovation, knowledge and perfromance: the case of the Biella Hospital). In AA. VV. Knowledge Management e Successo Aziendale. Atti del 26 Congresso Aidea. Agf AIDEA, Udine, Fattore G, "Assetti federali in Sanità: cosa possiamo imparare da Canada e Stati Uniti?" (Healthcare federalism: lessons from Canada and the US) In Falcitelli N, Trabucchi M, Vanara F (ed), Rapporto Sanità Il governo dei sistemi sanitari tra programmazione, devolution e valorizzazione delle autonomie, Bologna, Il Mulino, Fattore G, Longo F "Le tendenze evolutive nei sistemi regionali: analisi di alcuni piani sanitari rappresentativi" (Trends in regional health planning). In Anessi Pessina E., Cantù E., L'aziendalizzazione in sanità in Italia. Rapporto OASI 2002, Milan, Egea, Fattore G, Politiche centrali e regionali di governo della spesa farmaceutica a carico del SSN Central and regional pharmaceutical policies), in AAVV. Autonomia regionale e sistema sanitario. Atti del IV workshop di Economia Sanitaria, Torino, Cavallo MC, Fattore G, Tarricone R, Farmacoeconomia: Introduzione all analisi costi-efficacia, costi-utilità e delle decisioni (Pharmacoeconomics: introduction to cost-effectiveness, cost-utility and decision analysis), Milan, Promofarma,

13 Fattore G, La regolamentazione dei prezzi (Price regulation). In Lucioni C, Minghetti P. (a cura di). Economia e normativa del farmaco, Torino, Utet, Fattore G, Finanziamento e governo dell assistenza farmaceutica (Funding pharmaceutical care), In Lucioni C, Minghetti P. (a cura di). Economia e normativa del farmaco, Torino, Utet, Fattore G, Percudani M La valutazione economica dei trattamenti psicofarmacologici (Economic analysis of pharmaceutical treatments in psychiatry) in Altamura A. C. (a cura di), Argomenti di clinica e farmacoterapia delle psicosi maggiori, Milano, McGraw-Hill, Fattore G, Castaldi S "I Trust ospedalieri e il sistema sanitario pubblico di Londra" (Hospital Trusts in the public health care system in London), in Meneguzzo M. (a cura di) Strategie e gestione delle reti di aziende sanitarie, Milano, Egea, Fattore G, "La riforma del sistema sanitario svedese e il modello di offerta dei servizi della città di Stoccolma (Reforming healthcare in Stockholm) in Meneguzzo M. (a cura di) Strategie e gestione delle reti dei aziende sanitarie, Milano, Egea, Fattore G, "L'analisi di alcune unità sanitarie Locali" (A study on management innovation in Italian Local Health Units), in Borgonovi E. et al., Stato ed Economia. Lo Stato come Spende, Centro Studi Confindustria, Milano, Il Sole 24 Ore